Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Apr 2015 ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: Neoadjuvant Erlotinib in Endobronchial Ultrasound Confirmed Stage IIIA-N2 NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: Promising Results for Surgical Salvage of Local Recurrences after Stereotactic Ablative Radiotherapy in Patients With Early-Stage NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: EGFR Mutation Detection Possible from Ultrasound-Guided Fine Needle Aspirates Taken from Patients with Lung Cancer Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: VEGF SNPs Identified as Prognostic Markers for Bevacizumab Response in Patients with Advanced Non-Squamous NSCLC Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: Brigatinib (AP26113) Shows Intracranial Anti-tumour Activity in ALK-positive NSCLC patients with Brain Metastasis Following Crizotinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 Apr 2015 'Big Bang' Model of Cancer Heterogeneity Translational research
01 Apr 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Gardasil 9 Human Papillomavirus 9-Valent Vaccine (Recombinant, Adsorbed) Epidemiology/Etiology/Cancer Prevention
31 Mar 2015 Clinicians Hail Benefits of ESMO Clinical Practice Guidelines Gastrointestinal cancers
31 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for a Fixed Dose Combination Netupitant/Palonosetron Palliative and supportive care
30 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Lenvatinib Endocrine cancers - Anticancer agents & Biologic therapy
27 Mar 2015 ESMO Press Release: Clinical Trial Design in the Era of Targeted Therapies Translational research
25 Mar 2015 New Insights Into Survival Outcomes of Asian Americans Diagnosed with Cancer Epidemiology/Etiology/Cancer Prevention
25 Mar 2015 EMA's Pharmacovigilance Risk Assessment Committee Recommends Further Measures to Minimise Risk of Osteonecrosis of the Jaw with Bisphosphonate Medicine Palliative and supportive care
12 Mar 2015 FDA Approves First Therapy for High-Risk Neuroblastoma Cancer in Special Situations - Anticancer agents & Biologic therapy